von Willebrand factor cleaving protease (ADAMTS-13) antigen levels are decreased in patients with heparin-induced thrombocytopenia.

被引：0
|
作者：
Hoppensteadt, D
Cunanan, J
Walenga, JM
Ero, MP
Jeske, WP
Bick, R
Fareed, J
机构：
[1] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA
[2] Machaon Diagnost Inc, Oakland, CA USA
[3] Univ Texas, SW Med Ctr, Dallas, TX USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3970
引用
收藏
页码：72B / 72B
页数：1
相关论文
共 50 条
  • [21] The alterations of von Willebrand factor and its cleaving protease, ADAMTS-13 show an opposite change of direction in patients with liver cirrhosis
    Tornai, I.
    Papp, M.
    Udvardy, M. L.
    Orosz, P.
    Harsfalvi, J.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S106 - S106
  • [22] Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microanglopathic syndrome
    Latruada, A
    Rossi, E
    Calzarossa, C
    Candolfi, R
    Mannucci, PM
    HAEMATOLOGICA, 2003, 88 (09) : 1029 - 1034
  • [23] Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait
    Al-Awadhi, Anwar
    Adekile, Adekunle
    Marouf, Rajaa
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (01) : 117 - 123
  • [24] Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait
    Anwar Al-Awadhi
    Adekunle Adekile
    Rajaa Marouf
    Journal of Thrombosis and Thrombolysis, 2017, 43 : 117 - 123
  • [25] Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies:: The Swiss experience
    Hovinga, JAK
    Studt, JD
    Alberio, L
    Lämmle, B
    SEMINARS IN HEMATOLOGY, 2004, 41 (01) : 75 - 82
  • [26] von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis)
    Mannucci, PM
    Vanoli, M
    Forza, I
    Canciani, MT
    Scorza, R
    HAEMATOLOGICA, 2003, 88 (08) : 914 - 918
  • [27] Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease
    Miura, Mitsutoshi
    Kaikita, Koichi
    Matsukawa, Masakazu
    Soejima, Kenji
    Fuchigami, Shunichiro
    Miyazaki, Yuji
    Ono, Takamichi
    Uemura, Takashi
    Tsujita, Kenichi
    Hokimoto, Seiji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Matsui, Kunihiko
    Yamabe, Hiroshige
    Ogawa, Hisao
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (03) : 623 - 629
  • [28] Changes in plasma von Willebrand factor-cleaving protease(ADAMTS13) levels in patients with unstable angina
    Fuchigami, Shunichiro
    Kaikita, Koichi
    Soejima, Kenji
    Miura, Mitsutoshi
    Matsukawa, Masakazu
    Honda, Tsuyoshi
    Tsujita, Kenichi
    Sugiyama, Seigo
    Ogawa, Hisao
    CIRCULATION, 2007, 116 (16) : 91 - 91
  • [29] Von Willebrand Factor and levels of VWF-cleaving protease (ADAMTS-13) in neonates may be affected by pregnancy and perinatal complications of mothers and infants
    Strauss, T.
    Elisha, N.
    Ravid, B.
    Zivelin, A.
    Lubetsky, A.
    Morag, I.
    Kenet, G.
    THROMBOSIS RESEARCH, 2015, 135 : S69 - S70
  • [30] Low ADAMTS-13 predicts adverse outcomes in hospitalized patients with suspected heparin-induced thrombocytopenia
    Chan, Meng
    Zhao, Xinyang
    Zheng, X. Long
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2021, 5 (06)
12345